Jacobio Pharmaceuticals Group Co., Ltd. is an investment holding company, which engages in the research and development of pharmaceutical products. The company was founded on June 01, 2018 and is headquartered in Beijing, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 1167 is 1.23 HKD — it has decreased by −1.60% in the past 24 hours. Watch JACOBIO PHARMACEUTICALS GRP CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange JACOBIO PHARMACEUTICALS GRP CO LTD stocks are traded under the ticker 1167.
1167 stock has fallen by −6.11% compared to the previous week, the month change is a −22.64% fall, over the last year JACOBIO PHARMACEUTICALS GRP CO LTD has showed a −65.25% decrease.
1167 reached its all-time high on Feb 4, 2021 with the price of 25.35 HKD, and its all-time low was 1.25 HKD and was reached on Dec 17, 2024. View more price dynamics on 1167 chart. See other stocks reaching their highest and lowest prices.
1167 stock is 4.17% volatile and has beta coefficient of 1.43. Track JACOBIO PHARMACEUTICALS GRP CO LTD stock price on the chart and check out the list of the most volatile stocks — is JACOBIO PHARMACEUTICALS GRP CO LTD there?
Today JACOBIO PHARMACEUTICALS GRP CO LTD has the market capitalization of 970.99 M, it has decreased by −0.79% over the last week.
JACOBIO PHARMACEUTICALS GRP CO LTD is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
1167 earnings for the last half-year are −0.24 HKD per share, whereas the estimation was −0.29 HKD, resulting in a 18.52% surprise. The estimated earnings for the next half-year are 0.05 HKD per share. See more details about JACOBIO PHARMACEUTICALS GRP CO LTD earnings.
JACOBIO PHARMACEUTICALS GRP CO LTD revenue for the last half-year amounts to 0.00 HKD, despite the estimated figure of 0.00 HKD. In the next half-year revenue is expected to reach 212.98 M HKD.
1167 net income for the last half-year is −183.19 M HKD, while the previous report showed −208.33 M HKD of net income which accounts for 12.07% change. Track more JACOBIO PHARMACEUTICALS GRP CO LTD financial stats to get the full picture.
No, 1167 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 301.00 employees. See our rating of the largest employees — is JACOBIO PHARMACEUTICALS GRP CO LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JACOBIO PHARMACEUTICALS GRP CO LTD EBITDA is −394.72 M HKD, and current EBITDA margin is −615.01%. See more stats in JACOBIO PHARMACEUTICALS GRP CO LTD financial statements.
Like other stocks, 1167 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JACOBIO PHARMACEUTICALS GRP CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JACOBIO PHARMACEUTICALS GRP CO LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JACOBIO PHARMACEUTICALS GRP CO LTD stock shows the sell signal. See more of JACOBIO PHARMACEUTICALS GRP CO LTD technicals for a more comprehensive analysis. If you're still not sure, try looking for inspiration in our curated watchlists.